The U.S. has seen more measles cases this year than it has for any in the past three decades.

Plus, peptides could soon become more accessible in the U.S. if the FDA follows recommendations from an advisory panel.

People who take them are really interested in optimizing their health.

Maybe they are taking them

for purported muscle recovery, anti-aging purposes, or a more youthful skin. And the trade wars heat up,

as President Trump threatens new tariffs on the European Union. It's Friday, July 24th. I'm Alex

O'SAlev for the Wall Street Journal. This is the PM edition of What's News,

the top headlines and business stories that move the world today.

We begin today with a grim statistic. Measles cases in the U.S. have reached a new three-decade high.

The CDC today reported more than 2,300 confirmed

cases of measles so far this year. That's more than in all of last year. The disease has

spread because falling vaccination rates have made more communities vulnerable. Outbreaks in Utah and

South Carolina contributed to around half of the country's total cases, and cases are also

rising in Pennsylvania and Virginia. We're exclusively reporting that the Agriculture Department

is lifting a ban on importing cattle from Mexico. Cattle imports were cut off last year to try to stop

the spread of a parasite called a screw worm. It's not a food safety risk, but it's deadly to animals.

Mexico typically sends about a million calves across the border each year, and losing those cattle

has made a livestock shortage in the U.S. even worse. That shortage has sent prices for ground beef

and steak to record levels. Now, lifting the ban could lower those prices, but the move is contentious,

as U.S. ranchers are concerned about the spread of the parasite. The U.S. plans to resume imports

in 30 days.

For the past two days, an FDA advisory committee has held hearings about peptides. They voted on a series

...